Generation Bio Co. (GBIO)
Feb 9, 2026 - GBIO was delisted (reason: acquired by XOMA)
5.34
-0.40 (-6.97%)
Inactive · Last trade price on Feb 6, 2026

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2018
Period Ending
Dec '24 Dec '23 Dec '18
Therapeutics
19.89M
Therapeutics Growth
236.92%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2018
Period Ending
Dec '24 Dec '23 Dec '18
United States
19.89M
United States Growth
236.92%